Plasil Sonja L, Seth Amit, Homanics Gregg E
Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Front Genome Ed. 2020 Oct;2. doi: 10.3389/fgeed.2020.598522. Epub 2020 Oct 21.
The development of CRISPR/Cas9 technology has vastly sped up the process of mammalian genome editing by introducing a bacterial system that can be exploited for reverse genetics-based research. However, generating homozygous functional knockout (KO) animals using traditional CRISPR/Cas9-mediated techniques requires three generations of animals. A founder animal with a desired mutation is crossed to produce heterozygous F1 offspring which are subsequently interbred to generate homozygous F2 KO animals. This study describes an adaptation of the CRISPR/Cas9-mediated method to develop a cohort of homozygous gene-targeted KO animals in one generation. A well-characterized ethanol-responsive gene, , was chosen as a candidate gene for generation of KO mice as proof-of-concept. Previous studies have reported changes in ethanol-related behavioral outcomes in MyD88 KO mice. One-cell mouse embryos were simultaneously electroporated with four gRNAs targeting a critical Exon of MyD88 along with Cas9 protein. DNA and RNA analysis of founder mice revealed a complex mix of genetic alterations, all of which were predicted to ablate MyD88 gene function. Behavioral testing confirmed the hypothesis that successful one-generation KO of MyD88 would reproduce the decreased ethanol-induced sedative/hypnotic effects and increased ethanol consumption in males that were observed in previous studies. This study additionally compared responses of Mock treatment control mice generated through electroporation to controls purchased from a vendor. No substantial behavioral changes were noted between control cohorts. Overall, the CRISPR/Cas9 KO protocol reported here, which we call CRISPR Turbo Accelerated KnockOut (CRISPy TAKO), will be useful for reverse genetic screens of gene function in whole animals.
CRISPR/Cas9技术的发展通过引入一种可用于基于反向遗传学研究的细菌系统,极大地加速了哺乳动物基因组编辑的进程。然而,使用传统的CRISPR/Cas9介导技术生成纯合功能敲除(KO)动物需要三代动物。将具有所需突变的奠基动物进行杂交,以产生杂合的F1后代,随后将这些后代进行杂交,以生成纯合的F2 KO动物。本研究描述了对CRISPR/Cas9介导方法的一种改进,以在一代中培育出一批纯合基因靶向KO动物。选择一个特征明确的乙醇反应基因作为生成KO小鼠的候选基因,作为概念验证。先前的研究报道了MyD88 KO小鼠中与乙醇相关的行为结果的变化。将单细胞小鼠胚胎与靶向MyD88关键外显子的四种gRNA以及Cas9蛋白同时进行电穿孔。对奠基小鼠的DNA和RNA分析揭示了遗传改变的复杂组合,所有这些改变预计都会消除MyD88基因功能。行为测试证实了这一假设,即成功的MyD88一代KO将重现先前研究中观察到的雄性小鼠乙醇诱导的镇静/催眠作用降低和乙醇消耗量增加的现象。本研究还比较了通过电穿孔产生的模拟处理对照小鼠与从供应商处购买的对照小鼠的反应。在对照队列之间未观察到明显的行为变化。总体而言,本文报道的CRISPR/Cas9 KO方案,我们称之为CRISPR Turbo加速敲除(CRISPy TAKO),将有助于在全动物中对基因功能进行反向遗传筛选。